Cosmos Health Inc. Files 8-K on Shareholder Votes

TL;DR

Cosmos Health filed an 8-K on shareholder votes - watch for updates on company direction.

AI Summary

Cosmos Health Inc. filed an 8-K on November 21, 2024, reporting on matters submitted to a vote of security holders as of November 19, 2024. The filing details the company's corporate structure, including its state of incorporation (Nevada) and principal executive offices in Thessaloniki, Greece.

Why It Matters

This filing indicates that important decisions requiring shareholder approval have been made or are being presented, which could impact the company's strategic direction and governance.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of matters submitted to a vote of security holders and does not immediately indicate significant financial or operational risks.

Key Players & Entities

• Cosmos Health Inc. (company) — Registrant
• Nevada (jurisdiction) — State of incorporation
• Thessaloniki, Greece (location) — Principal executive offices
• November 19, 2024 (date) — Date of earliest event reported
• November 21, 2024 (date) — Date of report

FAQ

Filing Documents

• cosm_8k.htm (8-K) — 52KB
• 0001477932-24-007534.txt ( ) — 174KB
• cosm-20241119.xsd (EX-101.SCH) — 6KB
• cosm-20241119_lab.xml (EX-101.LAB) — 14KB
• cosm-20241119_cal.xml (EX-101.CAL) — 1KB
• cosm-20241119_pre.xml (EX-101.PRE) — 9KB
• cosm-20241119_def.xml (EX-101.DEF) — 2KB
• cosm_8k_htm.xml (XML) — 4KB

07

Item 5.07 Submission of Matters to a Vote of Security Holders. On November 19, 2024, Cosmos Health Inc. (the "Company") held its Annual Meeting of Shareholders (the "Meeting"). The following matters were submitted to a vote of the Company's shareholders at the Meeting: (1) the election of each of the six nominees for director; (2) the approval the issuance of shares of common stock pursuant to certain Common Stock Purchase Warrants Issued in connection with a warrant inducement; (3) the ratification of the appointment of the Company's independent registered public accounting firm; (4) the approval of the Company's 2024 Omnibus Equity Incentive Plan; and (4) the authorization of the Board of Directors to amend the Articles of Incorporation to effect reverse stock splits of the Company's outstanding common stock at their discretion.. At the Meeting, a total of 11,380,976 shares of common stock of the Company (the "Common Stock") voted in person or by proxy, out of 21,014,049 outstanding shares of Common Stock entitled to vote at the Meeting. This constituted approximately fifty-four (54%) percent of the issued and outstanding shares which is in excess of the one-third required for a quorum. Set forth below is the number of votes cast for, for, against, withheld, abstentions, broker non-votes and voting percentages as to each matter. 1. Election of Directors: Nomination For Withheld % Votes Affirmative 01 - Grigorios Siokas 10,327,893 1,070,083 90.61 % 02 - Demetrios G. Demetriades 8,510,238 2,860,738 74.84 % 03 - John J. Hoidas 7,859,458 3,469,518 69.37 % 04 - Dr. Anastasios Aslidis 9,536,525 1,834,451 83.87 % 05 - Dr. Manfred Ziegler 7,953,659 3,417,317 69.95 % 06 - Suhel Bhutawala 8,030,876 3,340,100 70.63 % 2. To approve the issuance of shares of common stock pursuant to certain Common Stock Purchase Warrants issued in connection with a warrant inducement: For Against Abstain % Votes Affirmative 8,006,

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. COSMOS HEALTH INC. Date: November 21, 2024 By: /s/ Georgios Terzis Georgios Terzis Chief Financial Officer -3-

View Full Filing

View this 8-K filing on SEC EDGAR